The world is currently experiencing a huge challenge which has affected all the industries and markets. Few markets have experienced a high growth in their demand while others have faced a downfall. The extent of growth or drop in the market statistics of different industries by COVID 19 plays an important role in how the future of businesses will shape up in the near future. We at Value Market Research provide you with an impact analysis of COVID 19 on this market with its latest update in the purchased version of the report.
Global Sickle Cell Disease Treatment Market Report By Type (Infection Prevention With Vaccination And Antibiotics, Blood Transfusion, The Medication Hydroxycarbamide, And A Transplant Of Bone Marrow Cells), Application (Hospitals, Ambulatory Surgical Centers, Clinics, And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026
ID:VMR11210465
February 2020
Report Formats:
As per this study, the Global Sickle Cell Disease Treatment Market was valued USD XX.X MN (by revenue) in 2019 and is anticipated to reach USD XX.X MN by 2026 with a CAGR of X.X%.
Sickle cell disease is a hereditary blood disorder characterized by rigid, abnormal, sickle-shaped red blood cells (RBCs). It is caused due to a mutation in beta-globin gene. The current treatment for sickle cell disease (SCD) consists of hydroxycarbamide and blood transfusion treatment. Most of the patients suffering from SCD are blood transfusion dependent and the only potential curative treatment for SCD is Bone Marrow Transplant (BMT).
Market Dynamics
The growing patient pool and high unmet medical needs are the key factors for the sickle cell disease treatment (SCD) market growth. Moreover, increasing investment by the government in order to improve the healthcare services are again pushing the market growth. However, the high cost of treatment and unavailability of required drugs are some of the factors that hinder the market growth. Whereas increasing support from government and regulatory bodies by means of research and development and approval of discovering a newer treatment for SCD disorder are some growth factors expected to drive the SCD market during the forecast period.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of sickle cell disease treatment.
Market Segmentation
The broad sickle cell disease treatment market has been sub-grouped into type and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Type
- Infection Prevention with Vaccination and Antibiotics
- Blood Transfusion
- The Medication Hydroxycarbamide
- A Transplant of Bone Marrow Cells
By Application
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Others
Regional Analysis
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for sickle cell disease treatment in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Europe Sickle Cell Disease Treatment Market By Revenue (USD MN)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the Sickle Cell Disease Treatment market include Acceleron Pharma, Alnylam Pharmaceuticals, Arena Pharmaceuticals, AstraZeneca, Baxter, Bluebird Bio, Bristol-Myers Squibb, Eli Lilly, Emmaus Life Sciences, Global Blood Therapeutics Novartis, Pfizer, Sangamo Therapeutics. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Sickle Cell Disease Treatment Market
2.2. Global Sickle Cell Disease Treatment Market Snapshot
3 . SICKLE CELL DISEASE TREATMENT – INDUSTRY ANALYSIS
3.1. Introduction
3.2. Market Drivers of Sickle Cell Disease Treatment Market
3.3. Market Restraints of Sickle Cell Disease Treatment Market
3.4. Opportunities of Sickle Cell Disease Treatment Market
3.5. Trends of Sickle Cell Disease Treatment Market
3.6. Porter’s Five Force Analysis of Sickle Cell Disease Treatment Market
3.7. Sickle Cell Disease Treatment Market Attractiveness Analysis
3.7.1 Market Attractive Analysis by Type
3.7.2 Market Attractive Analysis by Application
3.7.3 Market Attractive Analysis by Region
4 . VALUE CHAIN ANALYSIS
4.1. Sickle Cell Disease Treatment Value Chain Analysis
4.2. Sickle Cell Disease Treatment Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Sickle Cell Disease Treatment Raw Material Manufactures List
4.2.3. Price Trend of Sickle Cell Disease Treatment Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL SICKLE CELL DISEASE TREATMENT MARKET ANALYSIS BY TYPE
5.1 Overview by Type
5.2 Global Sickle Cell Disease Treatment Market Analysis by Type
5.3 Market Analysis of Infection Prevention with Vaccination and Antibiotics by Regions
5.4 Market Analysis of Blood Transfusion by Regions
5.5 Market Analysis of The Medication Hydroxycarbamide by Regions
5.6 Market Analysis of A Transplant of Bone Marrow Cells by Regions
6 . GLOBAL SICKLE CELL DISEASE TREATMENT MARKET ANALYSIS BY APPLICATION
6.1 Overview by Application
6.2 Global Sickle Cell Disease Treatment Market Analysis by Application
6.3 Market Analysis of Hospitals by Regions
6.4 Market Analysis of Ambulatory Surgical Centers by Regions
6.5 Market Analysis of Clinics by Regions
6.6 Market Analysis of Others by Regions
7 . GLOBAL SICKLE CELL DISEASE TREATMENT MARKET ANALYSIS BY GEOGRAPHY
7.1. Regional Outlook
7.2. Introduction
7.3. North America
7.3.1. Overview
7.3.2. North America Sickle Cell Disease Treatment Market Estimate by Market Segment
7.3.3. North America Sickle Cell Disease Treatment Market Estimate by Country
7.3.4. United State
7.3.5. Rest of North America
7.4. Europe
7.4.1. Overview
7.4.2. Europe Sickle Cell Disease Treatment Market Estimate by Market Segment
7.4.3. Europe Sickle Cell Disease Treatment Market Estimate by Country
7.4.4. United Kingdom
7.4.5. France
7.4.6. Germany
7.4.7 Rest of Europe
7.5. Asia Pacific
7.5.1. Overview
7.5.2. Asia Pacific Sickle Cell Disease Treatment Market Estimate by Market Segment
7.5.3. Asia Pacific Sickle Cell Disease Treatment Market Estimate by Country
7.5.4. China
7.5.5. Japan
7.5.6. India
7.5.7. Rest of Asia Pacific
7.6. Latin America
7.6.1. Overview
7.6.2. Latin America Sickle Cell Disease Treatment Market Estimate by Market Segment
7.6.3. Latin America Sickle Cell Disease Treatment Market Estimate by Country
7.6.4. Brazil
7.6.5. Rest of Latin America
7.7. Middle East & Africa
7.7.1. Overview
7.7.2. Middle East & Africa Sickle Cell Disease Treatment Market Estimate by Market Segment
7.7.3. Middle East & Africa Sickle Cell Disease Treatment Market Estimate by Country
7.7.4. Middle East
7.7.5. Africa
8 . COMPETITIVE LANDSCAPE OF THE SICKLE CELL DISEASE TREATMENT COMPANIES
8.1. Sickle Cell Disease Treatment Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments
9 . COMPANY PROFILES OF SICKLE CELL DISEASE TREATMENT INDUSTRY
9.1. Company Share Analysis
9.2. Market Concentration Rate
9.3. Acceleron Pharma
9.3.1. Company Overview
9.3.2. Financials
9.3.3. Products
9.3.4. Recent Developments
9.4. Alnylam Pharmaceuticals
9.4.1. Company Overview
9.4.2. Financials
9.4.3. Products
9.4.4. Recent Developments
9.5. Arena Pharmaceuticals
9.5.1. Company Overview
9.5.2. Financials
9.5.3. Products
9.5.4. Recent Developments
9.6. AstraZeneca
9.6.1. Company Overview
9.6.2. Financials
9.6.3. Products
9.6.4. Recent Developments
9.7. Baxter
9.7.1. Company Overview
9.7.2. Financials
9.7.3. Products
9.7.4. Recent Developments
9.8. Bluebird Bio
9.8.1. Company Overview
9.8.2. Financials
9.8.3. Products
9.8.4. Recent Developments
9.9. Bristol-Myers Squibb
9.9.1. Company Overview
9.9.2. Financials
9.9.3. Products
9.9.4. Recent Developments
9.10. Eli Lilly
9.10.1. Company Overview
9.10.2. Financials
9.10.3. Products
9.10.4. Recent Developments
9.11. Emmaus Life Sciences
9.11.1. Company Overview
9.11.2. Financials
9.11.3. Products
9.11.4. Recent Developments
9.12. Global Blood Therapeutics Novartis
9.12.1. Company Overview
9.12.2. Financials
9.12.3. Products
9.12.4. Recent Developments
9.13. Pfizer
9.13.1. Company Overview
9.13.2. Financials
9.13.3. Products
9.13.4. Recent Developments
9.14. Sangamo Therapeutics
9.14.1. Company Overview
9.14.2. Financials
9.14.3. Products
9.14.4. Recent Developments
10. IMPACT ANALYSIS OF COVID-19 OUTBREAK
10.1. Impact Analysis of Covid-19 Outbreak on the Market
10.1.1. Direct Impact on Production
10.1.2. Supply Chain and Market Disruption
10.1.3. Financial Impact on Firms and Financial Markets
10.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
10.3. Pre V/S Post COVID-19 Market
10.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
10.5. COVID-19: Micro and Macro Factor Analysis on the Market
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Global Market Snapshot
- Drivers of the Global Market Impact Analysis
- Restraints of the Global Market Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19 Market
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
- COVID-19: Micro and Macro Factor Analysis on the Market
- Global Sickle Cell Disease Treatment Market Analysis by Type (USD MN)
- Global Sickle Cell Disease Treatment Market Analysis in Infection Prevention with Vaccination and Antibiotics by Geography (USD MN)
- Global Sickle Cell Disease Treatment Market Analysis in Blood Transfusion by Geography (USD MN)
- Global Sickle Cell Disease Treatment Market Analysis in The Medication Hydroxycarbamide by Geography (USD MN)
- Global Sickle Cell Disease Treatment Market Analysis in A Transplant of Bone Marrow Cells by Geography (USD MN)
- Global Sickle Cell Disease Treatment Market Analysis by Application (USD MN)
- Global Sickle Cell Disease Treatment Market Analysis in Hospitals by Geography (USD MN)
- Global Sickle Cell Disease Treatment Market Analysis in Ambulatory Surgical Centers by Geography (USD MN)
- Global Sickle Cell Disease Treatment Market Analysis in Clinics by Geography (USD MN)
- Global Sickle Cell Disease Treatment Market Analysis in Others by Geography (USD MN)
- Global Sickle Cell Disease Treatment Market by Geography (USD MN)
- North America Sickle Cell Disease Treatment Market Analysis by Type (USD MN)
- North America Sickle Cell Disease Treatment Market Estimate by Application (USD MN)
- North America Sickle Cell Disease Treatment Market Estimate by Country (USD MN)
- United State Sickle Cell Disease Treatment Market Analysis by Type (USD MN)
- United State Sickle Cell Disease Treatment Market Estimate by Application (USD MN)
- Rest of North America Sickle Cell Disease Treatment Market Analysis by Type (USD MN)
- Rest of North America Sickle Cell Disease Treatment Market Estimate by Application (USD MN)
- Europe Sickle Cell Disease Treatment Market Analysis by Type (USD MN)
- Europe Sickle Cell Disease Treatment Market Estimate by Application (USD MN)
- United Kingdom Sickle Cell Disease Treatment Market Analysis by Type (USD MN)
- United Kingdom Sickle Cell Disease Treatment Market Estimate by Application (USD MN)
- France Sickle Cell Disease Treatment Market Analysis by Type (USD MN)
- France Sickle Cell Disease Treatment Market Estimate by Application (USD MN)
- Germany Sickle Cell Disease Treatment Market Analysis by Type (USD MN)
- Germany Sickle Cell Disease Treatment Market Estimate by Application (USD MN)
- Rest of Europe Sickle Cell Disease Treatment Market Analysis by Type (USD MN)
- Rest of Europe Sickle Cell Disease Treatment Market Estimate by Application (USD MN)
- Asia Pacific Sickle Cell Disease Treatment Market Analysis by Type (USD MN)
- Asia Pacific Sickle Cell Disease Treatment Market Estimate by Application (USD MN)
- Asia Pacific Sickle Cell Disease Treatment Market Estimate by Country (USD MN)
- China Sickle Cell Disease Treatment Market Analysis by Type (USD MN)
- China Sickle Cell Disease Treatment Market Estimate by Application (USD MN)
- Japan Sickle Cell Disease Treatment Market Analysis by Type (USD MN)
- Japan Sickle Cell Disease Treatment Market Estimate by Application (USD MN)
- India Sickle Cell Disease Treatment Market Analysis by Type (USD MN)
- India Sickle Cell Disease Treatment Market Estimate by Application (USD MN)
- Rest of Asia Pacific Sickle Cell Disease Treatment Market Analysis by Type (USD MN)
- Rest of Asia Pacific Sickle Cell Disease Treatment Market Estimate by Application (USD MN)
- Latin America Sickle Cell Disease Treatment Market Analysis by Type (USD MN)
- Latin America Sickle Cell Disease Treatment Market Estimate by Application (USD MN)
- Latin America Sickle Cell Disease Treatment Market Estimate by Country (USD MN)
- Brazil Sickle Cell Disease Treatment Market Analysis by Type (USD MN)
- Brazil Sickle Cell Disease Treatment Market Estimate by Application (USD MN)
- Rest of Latin America Sickle Cell Disease Treatment Market Analysis by Type (USD MN)
- Rest of Latin America Sickle Cell Disease Treatment Market Estimate by Application (USD MN)
- Middle East & Africa Sickle Cell Disease Treatment Market Analysis by Type (USD MN)
- Middle East & Africa Sickle Cell Disease Treatment Market Estimate by Application (USD MN)
- Middle East & Africa Sickle Cell Disease Treatment Market Estimate by Country (USD MN)
- Middle East Sickle Cell Disease Treatment Market Analysis by Type (USD MN)
- Middle East Sickle Cell Disease Treatment Market Estimate by Application (USD MN)
- Africa Sickle Cell Disease Treatment Market Analysis by Type (USD MN)
- Africa Sickle Cell Disease Treatment Market Estimate by Application (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisiton
- New Product Launch
- Other Developments
- Company Market Share Analysis, 2019
LIST OF FIGURES
- Research Scope of Sickle Cell Disease Treatment Report
- Market Research Process
- Market Research Methodology
- Global Sickle Cell Disease Treatment Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Type
- Market Attractiveness Analysis by Application
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Sickle Cell Disease Treatment Market Analysis by Type (USD MN)
- Global Sickle Cell Disease Treatment Market Analysis in Infection Prevention with Vaccination and Antibiotics by Geography (USD MN)
- Global Sickle Cell Disease Treatment Market Analysis in Blood Transfusion by Geography (USD MN)
- Global Sickle Cell Disease Treatment Market Analysis in The Medication Hydroxycarbamide by Geography (USD MN)
- Global Sickle Cell Disease Treatment Market Analysis in A Transplant of Bone Marrow Cells by Geography (USD MN)
- Global Sickle Cell Disease Treatment Market Analysis by Application (USD MN)
- Global Sickle Cell Disease Treatment Market Analysis in Hospitals by Geography (USD MN)
- Global Sickle Cell Disease Treatment Market Analysis in Ambulatory Surgical Centers by Geography (USD MN)
- Global Sickle Cell Disease Treatment Market Analysis in Clinics by Geography (USD MN)
- Global Sickle Cell Disease Treatment Market Analysis in Others by Geography (USD MN)
- Latin America Sickle Cell Disease Treatment Market by Revenue
- Middle East & Africa Sickle Cell Disease Treatment Market by Revenue
- Recent Development in Sickle Cell Disease Treatment Industry
- Company Market Share Analysis, 2019
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
Related Categories
Medical Devices
Objectives of Study
- Define and measure the global market
- Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
- Analyze and identify major market trends along with the factors driving or inhibiting the market growth
- Study the company profiles of the major market players with their market share
- Analyze competitive developments
Buy Chapters or Sections
Avail customized purchase options to meet your exact research needs:
- Buy sections of this report
- Buy country level reports
- Request for historical data
- Request discounts available for Start-Ups & Universities